Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Histological diagnosis, tumour stage and overall survival of the cases comprised in the present study

From: Heat shock protein expression in canine malignant mammary tumours

  Histological diagnosis Overall Survival (months)
n° 1 in situ carcinoma 23
n° 2 in situ carcinoma 22
n° 3 in situ carcinoma 36
n° 4 in situ carcinoma 29
n° 5 in situ carcinoma 24
n° 6 in situ carcinoma 27
n° 7 in situ carcinoma 23
n° 8 in situ carcinoma 29
n° 9 in situ carcinoma 60
n° 10 in situ carcinoma 28
STAGE I
n° 1 simple solid carcinoma 24
n° 2 simple tubular carcinoma 27
n° 3 carcinoma in benign tumour 22
n° 4 simple tubulopapillary carcinoma 27
n° 5 carcinoma in benign tumour 22
n° 6 simple solid carcinoma 26
n° 7 simple tubulopapillary carcinoma 33
n° 8 complex carcinoma 24
n° 9 simple tubulopapillary carcinoma 28
n° 10 simple carcinoma 42
STAGE II
n° 1 simple tubulopapillary carcinoma 36
n° 2 simple solid carcinoma 4
n° 3 simple solid carcinoma 1
n° 4 simple solid carcinoma 26
n° 5 simple solid carcinoma 9
n° 6 simple solid carcinoma 24
n° 7 simple solid carcinoma 1
n° 8 carcinoma in benign tumour 12
n° 9 simple tubulopapillary carcinoma 2
n° 10 simple solid carcinoma 26